STS食管癌切除术复合质量评分
STS基于2012-2014年胸外科数据库数据,开发了食管癌切除术的复合质量评分,由风险调整的死亡率和主要并发症两项指标构成。研究纳入167个中心4321例患者,手术死亡率3.1%,主要并发症率33.1%。年均手术量≥5例的70个中心复合评分可靠性为0.58,其中5个中心获三星,63个两星,2个一星;58.1%的中心因手术量不足无法获得可靠评分。
要点
- 复合评分由风险调整的死亡率和主要并发症构成,用于食管癌切除术质量评价。
- 年均手术量≥5例时复合评分可靠性为0.58(95%可信区间0.41-0.72)。
- 58.1%的参与中心因手术量不足无法获得可靠的星级评分。
核心结论
- STS基于风险调整的手术死亡率和主要并发症构建了食管癌切除术的复合质量评分。
- 该评分对年均手术量≥5例的中心具有良好可靠性,但近60%参与中心因手术量低无法获得星级评分。
研究设计与样本
- 研究使用STS胸外科数据库2012至2014年数据,纳入167个参与中心的4321例食管切除术患者。
- 采用95%贝叶斯可信区间确定星级评分,并以全国住院患者样本作为全国基准进行比较。
主要发现
- 研究人群手术死亡率为3.1%(N=135),主要并发症率为33.1%(N=1,429)。
- 167个参与中心中,70个中心年均食管切除术量≥5例,其复合评分可靠性为0.58(95%可信区间0.41至0.72)。
- 70个中心中,5个(7.1%)为三星,63个(90.0%)为两星,2个(2.9%)为一星。
- 58.1%(N=97)的STS参与中心因手术量不足无法获得可靠的复合评分。
- 与2012年全国住院患者样本队列相比,STS胸外科数据库参与中心的出院死亡率相当,术后住院时间更短。
关键数值与推荐
- 复合评分由风险调整的手术死亡率和主要并发症两项结局指标构成。
- 年均食管切除术量≥5例时,复合评分可靠性为0.58(95%可信区间0.41至0.72)。
临床怎么用
- 年均食管切除术量≥5例的中心可使用该复合评分进行质量评价和星级评定。
- 手术量较低的中心需注意复合评分可靠性不足,不宜直接依据星级评分进行质量比较。
局限性
- 近60%的参与中心因手术量低无法获得可靠的星级评分。
- 复合评分仅基于死亡率和主要并发症两项结局指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Society of Thoracic Surgeons (STS) has developed composite quality measures for cardiac surgical procedures and lobectomy for lung cancer. This study sought to develop a composite measure for esophagectomy for esophageal cancer. METHODS: The STS esophagectomy composite score is derived from two risk-adjusted outcomes: mortality and major complications. General Thoracic Surgery Database data were included from 2012 to 2014, and 95% Bayesian credible intervals were established to determine "star" ratings. STS participants were compared with the National Inpatient Sample as a national benchmark (including non-STS participants). RESULTS: The study population included 4,321 patients who underwent esophagectomy from 167 participating centers. The operative mortality rate was 3.1% (N = 135), and the major complication rate was 33.1% (N = 1,429). Of the 167 participants, 70 reported an average yearly volume of five or more esophagectomies during the study period. With this threshold, reliability for the composite score was 0.58 (95% credible interval, 0.41 to 0.72). Of these 70 participants, 5 (7.1%) were three star, 63 (90.0%) were two star, and 2 (2.9%) were one star. A majority of STS participants, 58.1% (N = 97), did not have sufficient volume to receive a reliable composite score. Benchmarked to the 2012 National Inpatient Sample cohort, STS General Thoracic Surgery Database participants have comparable discharge mortality rates and shorter postoperative lengths of stay. CONCLUSIONS: STS has developed a quality measure for esophageal cancer surgical procedures based on a composite score of risk-adjusted operative mortality rates and major complications. The composite rating for esophagectomy has good reliability for programs performing an average of five procedures annually, although almost 60% of participants are not eligible for a star rating because of lower procedure volumes.
引用
- The Society of Thoracic Surgeons Composite Score for Evaluating Esophagectomy for Esophageal Cancer. Ann Thorac Surg. 2017. PMID: 28385375. doi:10.1016/j.athoracsur.2016.10.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。